|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of chemotherapy for breast cancer.
Reviewed July 2009
Printer friendly page
| Results 1 to 11 displayed. |
| Title: |
Single agent versus combination chemotherapy for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Metastatic breast cancer is cancer that has advanced and spread beyond the breast and regional lymph nodes. Although many women will live with advanced disease for many years, treatment is aimed at the alleviation of symptoms rather than cure. The first...
|
| Date: |
Nov 2008
|
| Title: |
Bisphosphonates for breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
When breast cancer has spread to the bones (bone metastases ), bisphosphonate drugs (added to anti-cancer treatment for breast cancer) can reduce pain, fractures and other bone problems. Women and men with advanced breast cancer commonly develop bone me...
|
| Date: |
Jan 2007
|
| Title: |
Antitumour antibiotic containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced (metastatic) breast cancer is cancer that has spread beyond the breast. Treatment for metastatic disease usually involves some type of chemotherapy (anti-cancer drugs) to try to reduce the cancer. Chemotherapy drugs can either be given as a sin...
|
| Date: |
Oct 2006
|
| Title: |
Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Advanced breast cancer is treatable but not curable. Women with advanced breast cancer have an average survival of about 2 years, although some women may live for many years beyond this. It is therefore important to investigate different chemotherapy tr...
|
| Date: |
Aug 2005
|
| Title: |
Taxane containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Chemotherapy including taxane could improve survival and disease progression in women with advanced breast cancer, but more research is needed on which regimens help most. Advanced (metastatic) breast cancer is cancer that has spread beyond the breast. ...
|
| Date: |
Mar 2004
|
| Title: |
Platinum containing regimens for metastatic breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Chemotherapy containing platinum causes more adverse effects than other options but might not increase survival in women receiving their first treatments for advanced breast cancer. Advanced (metastatic) breast cancer has spread beyond the breast. Treat...
|
| Date: |
May 2003
|
| Title: |
Multi-agent chemotherapy for early breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Early breast cancer can be removed by surgery, and for many women the chance of the cancer returning (recurrence) is small. In some women however, the cancer does return. Chemotherapy (anti-cancer drugs) is used to try to prevent this, and to try to imp...
|
| Date: |
Aug 2001
|
| Title: |
Tamoxifen for early breast cancer
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
'Early' breast cancer means detectable cancer that can be surgically removed. However undetected cancer cells can develop after several years and cause death. Tamoxifen improves the 10-year survival for women after breast cancer surgery but there is unc...
|
| Date: |
Nov 2000
|
| Results 1 to 11 displayed. |
|